Click Here to return To Results

 

Treatment of Wilson Disease With Ammonium Tetrathiomolybdate, III. Initial Therapy in a Total of 55 Neurologically Affected Patients and Follow-up With Zinc Therapy Arch Neurol 60:379-385, Brewer,G.J.,et al, 2003 See this aricle in Pubmed Article Abstract Tetrathiomolybdate shows excellent efficacy in patients with Wilson disease who present with neurologic manifestations. With rapid escalation of dose, adverse effects from bone marrow suppression or aminotransferase elevations can occur.

Related Tags

(click to filter results - removes previous filter) adverse drug reaction aspartate aminotransferase bone marrow suppression hepatolenticular degeneration(Wilson's disease) liver function enzymes tetrathiomolybdate treatment of neurologic disorder

Click Here to return To Results